UT-15C (treprostinil diolamine)
TDE-PH-311
Phase 3 small_molecule completed
Quick answer
UT-15C (treprostinil diolamine) for Pulmonary Arterial Hypertension is a Phase 3 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Pulmonary Arterial Hypertension
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed